Methemoglobinemia induced by trimethoprim-sulfamethoxazole in a patient with systemic lupus erythematosus

16Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

We herein report a case of methemoglobinemia induced by trimethoprim-sulfamethoxazole (TMP/SMX). A 41-year-old woman with systemic lupus erythematosus (SLE) received TMP/SMX for prophylaxis of pneumocystis pneumonia (PCP) on the 7th day of hospitalization. She suddenly developed dyspnea and cyanosis on the 9th day of hospitalization. The level of oxygen saturation (SaO2) decreased, and the concentration of methemoglobin (MetHb) in the blood was elevated. We diagnosed the patient with methemoglobinemia induced by TMP/SMX. Methemoglobinemia should be considered in cases of sudden dyspnea following TMP/ SMX administration. © 2013 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Kawasumi, H., Tanaka, E., Hoshi, D., Kawaguchi, Y., & Yamanaka, H. (2013). Methemoglobinemia induced by trimethoprim-sulfamethoxazole in a patient with systemic lupus erythematosus. Internal Medicine, 52(15), 1741–1743. https://doi.org/10.2169/internalmedicine.52.0247

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free